http://online.wsj.com/articles/SB10001424052702303874504579374841914031168
U.S., India Clash Over Generic Drugs
FDA Takes Aim at Pharmaceutical Makers Including Ranbaxy
(JUST ONE OF THE STORIES)
Generic drugs account for nearly 85 percent of medicines prescribed in the United States and the government is relying on them to help rein in healthcare costs.
“We are losing control over what people are swallowing,” said Dr. Harry Lever, a cardiologist at the Cleveland Clinic who is trying raise awareness of the matter among U.S. lawmakers. “Now, when a patient comes in who is not doing well, the first thing I do is look at their drugs and find out who makes it.”
Increasingly, Lever said, he is recommending patients seek out generic drugs from specific manufacturers outside India.
“I’m tending to stay away from India,” he said. “There’s something wrong. Too many things are happening.”
Unease grows among U.S. doctors over Indian drug quality
http://in.reuters.com/article/2014/03/18/usa-india-genericdrugs-idINDEEA2H03120140318